Strategies to Reduce Rural Unnecessary Opioid Rx

Strategies to Reduce Rural Unnecessary Opioid Rx

This educational activity is jointly provided by AXIS Medical Education and Mississippi Hospital Association

In 2019, the CDC analyzed patient opioid prescription data from Athenahealth and found that the percentage of patients prescribed an opioid was higher in rural areas than in urban settings. In that study, 14 rural counties were among the 15 counties with the highest opioid prescribing rates. The CDC found that patients in the most rural counties had an 87% higher chance of receiving an opioid prescription, compared to those in large central metro counties.* aafp.org

Objectives:
1) Discuss primary causes of prescription opioid over-use.
2) Review the impact / increase of opioid use
during the COVID-19 pandemic.
3) Review ways to reduce new opioid starts.
2) Discuss strategies to decrease opioids post-operatively.
3) Discuss strategies that will assist the tapering of opioids in opioid-dependent patients.

Target Audience: Nursing Staff | Pharmacists | Quality

Agenda:

9:00 a.m.

Welcome and Introductions

MHA Team Member

9:05 a.m.

Review of Opioid Harms: A Framework

Steven Tremain, MD

9:10 a.m.

Preventing Inpatient and Procedural Harm

9:20 a.m.

Preventing New Starts

9:30 a.m.

Safe Management of Chronic Pain

9:38 a.m.

Treat Addiction: Starting MAT

9:45 a.m.

Provide Naloxone to High Risk Patients

9:50 a.m.

Q&A and Next Steps

MHA Facilitates

10:00 a.m.

Adjourn

MHA

 
                                                                                                                                                                   





                                                                     



Steve Tremain is a Physician Improvement Advisor with Cynosure Health. Board certified for 35 years in Family Medicine and now retired from active clinical practice, Dr. Tremain worked as a hospital-based clinician and teacher, and served as Chief Medical Officer for a large integrated public system for over 20 years. He was the executive sponsor for improvement teams that were awarded mentor status by the Institute for Healthcare Improvement in the areas of medication reconciliation, rapid response teams, and ventilator associated pneumonia.

Currently Dr. Tremain works as a national and international Improvement Advisor and serves as the national clinical lead or co-lead for the American Hospital Association/HRET HIIN efforts to improve antibiotic stewardship and to reduce harm from adverse drug events, VTE, sepsis, and C.difficile. In addition, he teaches and consults regarding the culture of safety, process reliability, leadership and physician engagement throughout the United States and Canada.

Steve is a Certified Physician Executive and a Fellow of the American College of Physician Executives. He earned his MD degree from the UCLA School of Medicine.



  ACCREDITED CONTINUING EDUCATION: ACCREDITATION STATEMENT 

In support of improving patient care, this activity has been planned and implemented by AXIS Medical Education and the Mississippi Hospital Association.  AXIS Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation for Pharmacists
This knowledge-based activity is approved for 1.0 contact hours of continuing pharmacy education credit - JA4008106-9999-21-052-L01-P.

Credit Designation for Nursing
AXIS Medical Education designates this continuing nursing education activity for 1.0 contact hours.
Learners are advised that accredited status does not imply endorsement by the provider or ANCC of any commercial products displayed in conjunction with an activity.

AXIS Contact Information - For information about the accreditation of this program please contact AXIS at info@axismeded.org.

Disclosure of Conflicts of Interest - AXIS Medical Education requires faculty, instructors, authors, planners, directors, managers, reviewers and other individuals who are in a position to control the content of this activity to disclose all real or apparent conflicts of interest they may have with ineligible companies. An ineligible entity is any organization whose primary business is t producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflicts of interest are identified and mitigated prior to initiation of the planning phase for an activity. 

AXIS has mitigated and disclosed to learners all relevant conflicts of interest disclosed by  staff, planners, faculty/authors, peer reviewers, or others in control of content for this activity. Disclosure of a relationship is not intended to suggest or condone bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation or activity. Disclosure information for faculty, authors, course directors, planners, peer reviewers, and/or relevant staff is provided with this activity.

The faculty Steve Tremain, M.D., FACPE reported no relevant financial relationships or relationships he has with ineligible companies of any amount during the past 24 months.

The directors, planners, managers and reviewers reported the following financial relationships they have with any ineligible company of any amount during the past 24 months:

Name of Planner/Manager

Reported Financial Relationship

Robin Powell

Nothing to disclose

Dee Morgillo, MEd, MT(ASCP), CHCP

Nothing to disclose

Holly M. Hampe, D.Sc., RN, MHA, MRM

Nothing to disclose


Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Requirements for credit:  

¨Attend/participate in the educational activity and review all course materials. 

¨Complete the CE Attestation process online by 11:59 pm ET  July 16, 2021. Instructions will be provided.

¨If you do not enter the online portal by the above date, you will not be able to retrieve your statement of participation.

¨Upon successful completion of the online form, your statement of completion will be presented to you to print.

¨Pharmacists, your record will be automatically uploaded to CPE Monitor.

When
6/16/2021 9:00 AM - 10:00 AM
Where
Webinar Info: Please Read Look for An Email To Confirm Event Registration UNITED STATES
 

Sign In